DKSH has signed an agreement to acquire Bio-Strategy, Australia's largest independent distributor of scientific instruments, aiming to enhance its presence in the technology and life sciences sectors.

Target Information

Bio-Strategy, established in 2003 and headquartered in Melbourne, Australia, is the leading independent distributor of scientific instruments within Australia and New Zealand. The company specializes primarily in the life sciences, medical & healthcare, and environmental & agricultural sectors, generating net sales exceeding CHF 40 million with strong profitability. With a dedicated team of over 100 professionals, Bio-Strategy serves a diverse clientele, providing products and services to approximately 1,200 customers, including several well-established blue-chip corporations.

As part of the acquisition, DKSH will acquire 100% of Bio-Strategy’s operations, along with its experienced management team and employees, who will integrate into DKSH’s Business Unit Technology. This move signifies DKSH's commitment to enhancing its market presence in these vital sectors.

Industry Overview

The Australian and New Zealand markets for scientific instruments and technology are characterized by robust growth, driven by advancements in life sciences and healthcare. The increasing demand for innovative instruments and technologies, coupled with